Definitive Contract HHSN272201600016C
Award Date 6/28/16
Potential Completion Date 11/30/23
Potential Value $6.2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Chicago, IL 60611, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Northwestern University. The award is a 5-year definitive contract with a potential value of $25,631,560.21 to support the "Structural Genomics Centers for Infectious Diseases" program. This contract does not have a set-aside designation. As the prime contractor, Northwestern University will provide research,...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB). The $9,327,649.94 contract is for "Targeted Clinical Research to Address Select Viral Infections" and does not have a set-aside designation. The contract includes clinical research at multiple sites, including UAB and its subcontractors, to address viral infections. Subcontractors...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Emory University. The $3,458,502.19 cost-no-fee contract is for "TARGETING THERAPEUTICS DEVELOPMENT TO RELIEVE BOTTLENECKS: OPTIMIZONG LEAD THERAPEUTIC COMPOUNDS AGAINST INFECTIOUS PATHOGENS." It has a period of performance through October 31, 2018. The contract is not designated as a set-aside. The contract has several...
- This federal contract award, valued at $7,415,829.00, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (DHHS), to Vanderbilt University Medical Center (VUMC) to support research on the "Genetic and Structural Basis for Virus Neutralization". The original solicitation, a pre-solicitation notice, indicates that NIAID is seeking research to enhance the...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) to conduct targeted clinical research addressing select viral infections. The $11,514,985.14 definitive contract has a completion date of February 28, 2026 and does not utilize any set-aside designation. As the prime contractor, UAB will be responsible for participating in protocol...
- This firm-fixed-price delivery order was awarded to Georgetown University by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract, valued at $189,000, is for a "Comprehensive Panel for Viruses" and was issued under NIAID's "In Vitro Antimicrobial Assessments 2011-2018" indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The contract has a period of performance through...
- This is a firm-fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Georgetown University for a "Comprehensive Panel for Viruses" project. The $167,700.00 contract is a task order under NIAID's larger In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract does not have a set-aside designation. Georgetown University,...
- This is a $11,665,406.62 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Washington University, a private university in St. Louis, Missouri. The contract supports "B Cell Epitope Discovery and Mechanisms of Antibody Protection" research, with no set-aside designation. The contract includes several subcontractors: Vanderbilt University Medical Center is developing panels of human monoclonal antibodies against flaviviruses and...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Georgetown University. The contract is a delivery order under the NIAID Animal Models of Infectious Diseases 2010-2017 contract vehicle, which is a cost-no-fee contract. Georgetown University, a private non-profit university, is the prime contractor. The contract has a ceiling value of $5,746,219.71 and was awarded on March 22, 2010...
- This federal contract award, valued at $12,612,049, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to the University of Pittsburgh. The contract is for research and development related to infectious disease models, including the provision of small animal models, non-human primate models, animal replacement models, and specialized reagents. This contract is part of a larger $146.3 million...